Stockreport

Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium

Coya Therapeutics, Inc.  (COYA) 
PDF Serum 4-Hydroxynonenal (4-HNE) levels are significantly increased in ALS patients- the higher the 4-HNE level, the faster the progression and shorter the survival;Serum [Read more]